<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Department of Internal Medicine</title>
<link href="http://localhost:8080/xmlui/handle/123456789/613" rel="alternate"/>
<subtitle/>
<id>http://localhost:8080/xmlui/handle/123456789/613</id>
<updated>2026-04-05T22:59:57Z</updated>
<dc:date>2026-04-05T22:59:57Z</dc:date>
<entry>
<title>Prevalence and distribution of primary glomerular  diseases in Africa: a systematic review and meta analysis of observational studie</title>
<link href="http://localhost:8080/xmlui/handle/123456789/2540" rel="alternate"/>
<author>
<name>Mbah, Ikechukwu</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/2540</id>
<updated>2024-07-08T20:23:03Z</updated>
<published>2023-08-09T00:00:00Z</published>
<summary type="text">Prevalence and distribution of primary glomerular  diseases in Africa: a systematic review and meta analysis of observational studie
Mbah, Ikechukwu
Glomerulonephritis (GN) is a predominant cause of &#13;
kidney failure in Africa. The prevalence of primary &#13;
GNs varies widely across Africa depending on the &#13;
relative proportion of secondary GNs and genetic &#13;
predispositions. We assessed the overall and sub regional prevalence of primary GN and its histologic &#13;
subtypes in Africa. We searched PubMed, EMBASE &#13;
and African Journals Online for studies of biopsy proven primary GNs across all age groups in Africa &#13;
published between 2010 and 2022. Data for &#13;
primary GNs [minimal change disease (MCD), focal &#13;
segmental glomerulosclerosis (FSGS), membranous &#13;
nephropathy (MN), mesangioproliferative GN &#13;
(MesPGN), membranoproliferative GN (MPGN), &#13;
post-infectious GN (PIGN), IgA Nephropathy (IgAN), &#13;
and crescentic GN (CresGN)] were extracted. Pooled &#13;
prevalence was determined using the random &#13;
effects model. Seventeen eligible articles (n = 6,494 &#13;
individuals) from 8 African countries met the &#13;
inclusion criteria. The overall pooled prevalence of &#13;
FSGS, MCD, MN, MPGN, MesPGN, PIGN, IgAN and &#13;
CresGN was 26.10%, 22.40%, 8.40%, 6.40%, 6.40%, &#13;
2.60%, 2.60%, 1.40%, respectively. Only 4 studies &#13;
(23.5%) used light microscopy (LM), &#13;
immunofluorescence (IF), and electron microscopy&#13;
(EM) for diagnosis. There were significant &#13;
differences in the distribution of histologic subtypes &#13;
in the paediatric compared to the adult population &#13;
and across geographic sub-regions, with West &#13;
Africa having a higher prevalence of FSGS. Overall, &#13;
the dominance of FSGS across most regions and age &#13;
groups has implications for disease diagnosis and &#13;
ongoing care. Research efforts to understand the &#13;
impact of this trend on kidney disease outcomes &#13;
and efforts to improve kidney biopsy practice as a &#13;
means of early disease detection are needed in African
Systemic Review and Meta-analysis
</summary>
<dc:date>2023-08-09T00:00:00Z</dc:date>
</entry>
<entry>
<title>Pattern of non-communicable diseases seen in a tertiary hospital in Keffi, North Central Nigeria</title>
<link href="http://localhost:8080/xmlui/handle/123456789/2539" rel="alternate"/>
<author>
<name>Mbah, Ikechukwu</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/2539</id>
<updated>2024-07-08T20:21:27Z</updated>
<published>2019-10-22T00:00:00Z</published>
<summary type="text">Pattern of non-communicable diseases seen in a tertiary hospital in Keffi, North Central Nigeria
Mbah, Ikechukwu
Background: The burden of noncommunicable diseases(NCDs) is increasing in developing countries largely&#13;
due to epidemiological transition. In this study, data of individuals who were seen in specialist medical&#13;
clinics and wards in a hospital located in a fast-growing urban area were analyzed to identify the pattern&#13;
of NCDs among the attendees.&#13;
Materials and Methods: A retrospective study of available registers and electronic medical records of adult&#13;
patients with diagnoses of medical disorders seen between January 2006 and January 2016 at the specialist&#13;
medical outpatient clinics and medical, emergency, and intensive care wards of Federal Medical Centre,&#13;
Keffi, Nasarawa State, Nigeria, was carried out between January 2015 and January 2016. Medical records&#13;
of 682 individuals were reviewed, and their data were extracted and analyzed.&#13;
Results: Females(59.1%) and people in the middle-age group (44.6%) constituted majority of adult participants&#13;
who were seen in the facility for medical diseases. The prevalence of NCDs was 64.4%, with cardiovascular&#13;
disease (CVD) being the most common (37.7%). Hypertension was the most prevalent CVD (70%).&#13;
Conclusion: NCDs were the predominant diseases seen at the specialist clinics and medical wards in the&#13;
study. CVDs were the most prevalent NCDs followed by endocrine diseases.
Original Article
</summary>
<dc:date>2019-10-22T00:00:00Z</dc:date>
</entry>
<entry>
<title>Obesity and hypoglycaemia in type 2 diabetes mellitus outpatients on insulin therapy in Nigeria–data from the multicentre evaluation of type 2 diabetes mellitus outpatients patients on insulin therapy. METOIN Study</title>
<link href="http://localhost:8080/xmlui/handle/123456789/2538" rel="alternate"/>
<author>
<name>Nkpozi, MO, IO, GE, K, C, FA Mbah. , Bozimo, Akhidue. Ezeude, Owolabi</name>
</author>
<author>
<name>Nkpozi Mbah., MO, IO, GE, K, C, FA MO, IO, GE, K, C, FA Bozimo, Akhidue. Ezeude, Owolabi</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/2538</id>
<updated>2024-07-08T20:17:31Z</updated>
<published>2024-02-16T00:00:00Z</published>
<summary type="text">Obesity and hypoglycaemia in type 2 diabetes mellitus outpatients on insulin therapy in Nigeria–data from the multicentre evaluation of type 2 diabetes mellitus outpatients patients on insulin therapy. METOIN Study
Nkpozi, MO, IO, GE, K, C, FA Mbah. , Bozimo, Akhidue. Ezeude, Owolabi; Nkpozi Mbah., MO, IO, GE, K, C, FA MO, IO, GE, K, C, FA Bozimo, Akhidue. Ezeude, Owolabi
Background and Objective: Despite the obvious benefits of early insulin use in&#13;
achieving good glycaemic control, insulin linked overweight/obesity and&#13;
hypoglycaemia are sources of concern and worry. Burden of these side effects among&#13;
type 2 diabetes mellitus (T2DM) outpatients on insulin therapy in Nigeria is&#13;
unknown.&#13;
Subjects and Methods: This was a prospective, cross sectional and observational&#13;
study in which consenting T2DM outpatients that meet the inclusion criteria for the&#13;
study in five tertiary health facilities were simultaneously recruited and relevant data&#13;
obtained via investigator-administered questionnaire. Data obtained which included&#13;
gender, arthropometric measures, hypoglycaemia and where it was treated were&#13;
analyzed using Statistical Package for Social Sciences (SPSS) version 23.0 software.&#13;
Results: A total of 245 T2DM outpatients were recruited into the study, made up of&#13;
107 (43.7%) male and 138 (56.3%) female. Of this, 121 (49.8%) patients were&#13;
overweight while 70 (28.7%) were obese. Among the patients, 104 (42.4%) T2DM&#13;
outpatients on insulin therapy reported hypoglycaemia which was mild in 83 (79.8%)&#13;
of the patients&#13;
Conclusion: A significant number of the type 2 DM outpatients on insulin therapy&#13;
were overweight/obese with mild hypoglycaemia in a majority of them.
</summary>
<dc:date>2024-02-16T00:00:00Z</dc:date>
</entry>
<entry>
<title>The Relationship between Metabolic syndrome and Progressive renal disease: The Zankli Experience</title>
<link href="http://localhost:8080/xmlui/handle/123456789/2461" rel="alternate"/>
<author>
<name>MBAH, I O</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/2461</id>
<updated>2024-07-02T14:35:03Z</updated>
<published>2006-01-01T00:00:00Z</published>
<summary type="text">The Relationship between Metabolic syndrome and Progressive renal disease: The Zankli Experience
MBAH, I O
</summary>
<dc:date>2006-01-01T00:00:00Z</dc:date>
</entry>
</feed>
